Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Liposomal technology encases glutathione in a protective barrier designed for gentle digestion and optimal absorption
Sensitivity of KRAS mutant colorectal cancers to combination therapy that co-targets MEK and CDK4/6
JAMA Oncol
The innovation of self-assembled peptides has been proven to demonstrate high biocompatibility and biological activities, making them attractive as therapeutic drugs [160]
Not excess
US$ 24.28
US$ 25.79
US$ 29.65
